Kalmar Central Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT00740116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Dept. of Obstetrics and Gynecology, Kalmar Central Hospital, 391 85 Kalmar

Active Ingredients

Drugs in Phase 4 Trials (2)

sodium chloride (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 4)

Ovarian Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2